Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.
about
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosisComprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseasesBorrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2Atacicept: targeting B cells in multiple sclerosisThe pathogenesis of lyme neuroborreliosis: from infection to inflammationNeuroinvasion and Inflammation in Viral Central Nervous System InfectionsB Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic InterventionsB Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized InflammationThe Ins and Outs of B Cells in Multiple SclerosisDiagnostic biomarkers in multiple sclerosis.Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein.Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome.Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid.Identification of peptide targets in neuromyelitis optica.Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencingSystemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein.Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected SubjectsCD19 as a molecular target in CNS autoimmunity.Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.The double-edged sword of autoimmunity: lessons from multiple sclerosis.Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis opticaUptake and presentation of myelin basic protein by normal human B cells.Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targetsGenetic variants are major determinants of CSF antibody levels in multiple sclerosis.Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosisMeasles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSFThe Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Studyγ-Secretase directly sheds the survival receptor BCMA from plasma cellsImmune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.Epstein-barr virus: environmental trigger of multiple sclerosis?Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection.Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune DiseaseNeurological disorders and therapeutics targeted to surmount the blood-brain barrierThe Role of Latently Infected B Cells in CNS Autoimmunity.Dysregulated Epstein-Barr virus infection in the multiple sclerosis brainA Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
P2860
Q21144285-BE4F7149-3873-49AE-B076-9A51992C951CQ24273331-BA39EC4D-98F7-44B5-A995-BB6675EDB56AQ24309415-E80B1758-4A91-4C02-A032-C93A9B8674CEQ24628925-D418523B-02DC-4A90-AC87-46F2B26C39B2Q24670918-B7B25ED9-E481-4F77-8AC3-B7D427EC8130Q26745615-6387BD47-E3F0-4F2E-8B30-A55FC8E54A33Q26770664-940797D2-320B-4028-AEAE-1E7B346A0AD0Q26770852-D8673727-E28C-4FE0-A014-6AA66D8BB6F1Q26776542-3F58BEF9-9025-4183-8BBB-00641F80FBD0Q30598338-0E6F7A58-4686-428A-9CC0-D304CC8209A7Q33264770-D2FE3C5F-3556-4A4A-A288-9BEBCB7171B0Q33332176-1A0110C2-7C02-45D7-B6BB-1253061585E7Q33599648-7CA96E71-44F6-4E14-AD8E-915207D66951Q33745475-33638E01-D51D-4817-AF79-37F2A1AF5383Q33914842-50F1A359-F32C-41D0-B761-97D66CBBE8D5Q34073320-02609AB5-EE2B-41CA-8724-400111482B6AQ34193087-E0691C80-CC69-4260-830C-051DA7208BB1Q34613311-AC0A443C-575C-48BB-A37C-02CF791F610BQ34773444-42D09296-5B74-4D4B-B636-DCD14ED44675Q34792090-8BE83B75-7268-41A6-A11C-32B84CF882FAQ34976749-C4E48235-7605-43BF-BED8-7991567D141FQ35077861-B1721BBE-0C65-44B2-97D6-37A00C17266FQ35155753-9D846C03-49C5-4FB8-A219-7CA75B766BBEQ35234452-5485BC3E-FAD9-4D2D-A796-1585C4E2ADEFQ35424431-55E3A70C-DCF7-47C3-B72A-9C9EA556D638Q35463552-0C85E786-D71B-4B8C-BB38-0B6AEC4856D8Q35533986-C6D54814-36A7-4CF1-AD49-6556DBB42DDAQ35619174-E213AF08-47A4-4AAE-A800-FFD6962BB110Q35755470-72E4C248-6F5C-45B6-B864-2FC26C7CE349Q35804573-D14888DC-FF6C-46D1-AB3E-6E6F26BFE04AQ35814239-8A3B99FC-2DD7-4A0C-A06A-2379E95CDCA3Q35848490-443DB05E-DB72-470D-AE62-BEE156FEE492Q35891605-5F8205BF-A585-4761-9428-E00D13B1D4F6Q35914342-29833A83-9CB0-4633-BDC5-4E2BEEB26558Q36082102-D48D4144-6636-4AED-AD1A-BCA44801CD33Q36097332-7741731E-F2B2-47BC-BB77-B8DFB3FF27B8Q36119574-F0EF1F8F-D550-4D4B-8A1C-EDABE25F9991Q36216025-E2BAF218-2BD2-43B6-8E5C-802D1494D4DDQ36229219-A9B31FEE-F043-4E67-B643-403701BA14F8Q36455070-A8F27FA4-5EE8-4D18-A0FC-F36C201D1EA0
P2860
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Short-lived plasma blasts are ...... course of multiple sclerosis.
@en
Short-lived plasma blasts are ...... course of multiple sclerosis.
@nl
type
label
Short-lived plasma blasts are ...... course of multiple sclerosis.
@en
Short-lived plasma blasts are ...... course of multiple sclerosis.
@nl
prefLabel
Short-lived plasma blasts are ...... course of multiple sclerosis.
@en
Short-lived plasma blasts are ...... course of multiple sclerosis.
@nl
P2093
P356
P1433
P1476
Short-lived plasma blasts are ...... course of multiple sclerosis.
@en
P2093
Berit Rosche
Bernhard Hemmer
Friederike Vogel
Joachim Sayn
Norbert Sommer
Sabine Cepok
Verena Grummel
P304
P356
10.1093/BRAIN/AWH486
P407
P577
2005-03-30T00:00:00Z